Dioscorea bulbifera L.induces liver injury in mice partly through bile acids metabolic disorders and gut microbiota dysbiosis mediated by the YY1-FXR/Nrf2 signaling pathwayOA
Background:This study aimed to comprehensively elucidate the hepatotoxic effects of Dioscorea bulbifera L.(DBL)in mice and to explore the underlying molecular mechanisms.Methods:Mice were administered different doses of DBL via intragastric gavage for 21 days.Organ indices of multiple organs were then measured,and histopathological changes were systematically evaluated.Particular attention was paid to biochemical markers and hepatic histopathological alterations associated with liver injury.Subsequently,the composition of the gut microbiota in colonic contents was analyzed using 16S rDNA sequencing,and the levels of short-chain fatty acids(SCFAs)were determined by gas chromatography(GC).Furthermore,protein expression levels of YinYang 1(YY1),Farnesoid X Receptor(FXR),Nuclear factor erythroid 2-related factor 2(Nrf2),and bile acids(BAs)-related proteins in the liver were assessed by Western blot analysis.Results:Our findings revealed that DBL induced varying degrees of multi-organ toxicity in mice,with the most pronounced hepatotoxicity observed.Liver injury was induced in a dose-dependent manner,accompanied by increased hepatic inflammation and oxidative stress,as well as enhanced hepatocyte apoptosis.Furthermore,DBL may modulate the YY1-FXR/Nrf2 signaling pathway,leading to upregulation of BAs-related proteins such as cholesterol 7α-hydroxylase(CYP7A1),while downregulating other BAs-related proteins,including sodium taurocholate cotransporting polypeptide(NTCP),bile salt export pump(BSEP),multidrug resistance protein 2(MRP2),and P-glycoprotein(P-gp).These changes promoted excessive BAs synthesis and impaired the excretion and reabsorption of BAs,ultimately disturbing BAs homeostasis.Additionally,DBL induces gut microbiota dysbiosis and reduces SCFAs production,leading to intestinal damage and disruption of intestinal barrier integrity.Conclusion:DBL-induced hepatotoxicity may be associated with altered expression of the YY1-FXR/Nrf2 signaling pathway and BAs–related proteins,accompanied by increased hepatic BAs accumulation and gut microbiota dysbiosis.
Bo-Shen Zhao;Yun-Dong Xie;Xin Wang;Yu-Han Zhang;Hong-Zhe Zhu;Lei-Lei Shi;Hui-Zi Shangguan;Ling Ding;Shu-Hong Zhu;Cui-Cui Ren;Ji-Ping Liu
Department of Pharmacology,Shaanxi University of Chinese Medicine,Xianyang 712046,ChinaDepartment of Pharmacology,Shaanxi University of Chinese Medicine,Xianyang 712046,ChinaDepartment of Pharmacology,Shaanxi University of Chinese Medicine,Xianyang 712046,ChinaDepartment of Pharmacology,Shaanxi University of Chinese Medicine,Xianyang 712046,ChinaDepartment of Pharmacology,Shaanxi University of Chinese Medicine,Xianyang 712046,ChinaDepartment of Pharmacology,Shaanxi University of Chinese Medicine,Xianyang 712046,ChinaDepartment of Pharmacology,Shaanxi University of Chinese Medicine,Xianyang 712046,ChinaDepartment of Pharmacology,Shaanxi University of Chinese Medicine,Xianyang 712046,ChinaDepartment of Pharmacy,First Hospital of Xi''an,Xi''an 710002,ChinaDepartment of Pharmacy,First Hospital of Xi''an,Xi''an 710002,ChinaDepartment of Pharmacology,Shaanxi University of Chinese Medicine,Xianyang 712046,China Key Laboratory of Pharmacodynamic Mechanism and Material Basis of Traditional Chinese Medicine,Shaanxi Administration of Traditional Chinese Medicine,Xianyang 712046,China Engineering Research Center of Brain Health Industry of Chinese Medicine,Universities of Shaanxi Province,Xianyang 712046,China
医药卫生
DioscoreabulbiferaL.liverinjurybileacidsmetabolismgutmicrobiotashort-chainfattyacids
《Traditional Medicine Research》 2026 (8)
P.15-27,13
supported by the National Natural Science Foundation of China(82204790)Shaanxi University of Chinese Medicine Science and Technology Program(2024-LJRC-04)Shaanxi Province Natural Science Foundation(2024JC-YBMS-759)Qinchuangyuan TCM Industry Innovation Project(L2024-QCY-ZYYJJQ-X29).
评论